Oxford Molecular Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
9
Oxford Molecular General Information
Description
Developer of chemical information management and decision-support software catering to researchers in the pharmaceutical and biotechnology research industries. The company's platform bioinformatics data management and analysis platform are used for the analysis of DNA and protein sequence data, assisting researchers in identifying the genetic basis for new pharmaceutical, diagnostic and agricultural products.
Contact Information
Website
www.oxmol.co.ukCorporate Office
- The Medawar Centre
- Oxford Science Park
- Oxford OX4 4GA
- England, United Kingdom
Corporate Office
- The Medawar Centre
- Oxford Science Park
- Oxford OX4 4GA
- England, United Kingdom
Oxford Molecular Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oxford Molecular Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oxford Molecular Patents
Oxford Molecular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-0777882-A2 | Relational database management system for chemical structure storage, searching and retrieval | Inactive | 10-Aug-1994 |
Oxford Molecular Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Oxford Molecular FAQs
-
When was Oxford Molecular founded?
Oxford Molecular was founded in 1989.
-
Where is Oxford Molecular headquartered?
Oxford Molecular is headquartered in Oxford, United Kingdom.
-
What industry is Oxford Molecular in?
Oxford Molecular’s primary industry is Other Healthcare Services.
-
Is Oxford Molecular a private or public company?
Oxford Molecular is a Private company.
-
What is the current valuation of Oxford Molecular?
The current valuation of Oxford Molecular is .
-
What is Oxford Molecular’s current revenue?
The current revenue for Oxford Molecular is .
-
How much funding has Oxford Molecular raised over time?
Oxford Molecular has raised $88.6M.
-
Who are Oxford Molecular’s investors?
AMT Ventures, Baring Brothers International, Edelson Technology Partners, Oxford Spin-out Equity Management, and Pharmacopeia are 5 of 7 investors who have invested in Oxford Molecular.
-
When was Oxford Molecular acquired?
Oxford Molecular was acquired on 01-Jun-2001.
-
Who acquired Oxford Molecular?
Oxford Molecular was acquired by Dassault Systèmes BIOVIA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
